Miles to Go and Nowhere to Sleep | NEJM
With no grandmaster moving the chess pieces of U.S. health care, weighing population density and disease distribution, rural health relies on urban centers — and the kindness of individual strangers.
Related Articles
Leaving FDA, Califf is unapologetic — and warns of staff departures
In an interview, outgoing FDA commissioner Robert Califf was wary of the Trump administration but unapologetic about controversial decision during his term.
Cervical Cancer | NEJM
Accounting for approximately 350,000 deaths annually worldwide, cervical cancer is preventable with HPV vaccination and screening. Newer chemotherapy, radiotherapy, and immunotherapy techniques hav…
Can the Mediterranean Diet Boost Your Memory?
WEDNESDAY, Jan. 8, 2025 (HealthDay News) — The Mediterranean diet is renown for its ability to improve heart health and help folks lose weight.Now a…
Non-utilisation of postpartum services in northwestern Nigeria: analyses of trend and social determinants from 2003 to 2018
Objective To assess the prevalence of non-utilisation of postpartum services in northwestern Nigeria from 2003 to 2018 and to identify and estimate the influence of…
New science journalism guide in Croatian
There is a new guide for aspiring science journalists in Croatia and neighbouring countries. The guide, called Ten short lessons in science journalism, has been…
Biopharma in 2025: Outlook for Obesity Meds, Drug Prices, Regulation & More – MedCity News
Metabolic medicines dominated life sciences headlines in 2024, a trend expected to continue into the new year. Other things to look for include more widespread…
Winter surge of hMPV in China and elsewhere not unusual, WHO says
Rising cases of common respiratory illnesses in China and elsewhere around the Northern Hemisphere are within the range expected for winter, with no unusual outbreaks…
Fitness Faceoff: Cardio vs. Strength Training | Cleveland Clinic
Some people think the only good workout is a cardio workout. Others believe that muscle-burning strength workouts is the best choice. Listen as exercise physiologist…
LB-102 Shows Promise in Reducing Acute Schizophrenia Symptoms: New Phase 2 Data
Phase 2 data demonstrates the effectiveness of LB-102, developed with the potential to be the first-in-class benzamide antipsychotic, for adults with acute schizophrenia.
Leaving FDA, Califf is unapologetic — and warns of staff departures
In an interview, outgoing FDA commissioner Robert Califf was wary of the Trump administration but unapologetic about controversial decision during his term.